Deka Bank Deutsche Girozentrale C4 Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

  • $54.1 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$5.06 - $26.46 $100,187 - $523,908
-19,800 Closed
0 $0
Q1 2022

Apr 28, 2022
BUY
$19.99 - $33.23 $35,982 - $59,813
1,800 Added 10.0%
19,800 $477,000
Q4 2021

Feb 02, 2022
BUY
$29.39 - $46.86 $529,020 - $843,480
18,000 New
18,000 $593,000

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $170M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email